Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

PDZK1IP1

Introduction

PDZK1-interacting protein 1 is a protein that in humans is encoded by the PDZK1IP1 gene.[1][2][3][4][5]

Interactions

Interactions

PDZK1IP1 has been shown to interact with PDZK1.[3][4][6]

References

References

  1. ↑ Kocher O, Cheresh P, Brown LF, Lee SW (Feb 1999). “Identification of a novel gene, selectively up-regulated in human carcinomas, using the differential display technique”. Clin. Cancer Res. 1 (10): 1209–15. PMID 9815914.
  2. ↑ Kocher O, Cheresh P, Lee SW (Sep 1996). “Identification and partial characterization of a novel membrane-associated protein (MAP17) up-regulated in human carcinomas and modulating cell replication and tumor growth”. Am. J. Pathol. 149 (2): 493–500. PMC 1865305. PMID 8701988.
  3. ↑ 3.0 3.1 Silver DL, Wang N, Vogel S (Jul 2003). “Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels”. J. Biol. Chem. 278 (31): 28528–32. doi:10.1074/jbc.M304109200. PMID 12754212.
  4. ↑ 4.0 4.1 Pribanic S, Gisler SM, Bacic D, Madjdpour C, Hernando N, Sorribas V, Gantenbein A, Biber J, Murer H (Sep 2003). “Interactions of MAP17 with the NaPi-IIa/PDZK1 protein complex in renal proximal tubular cells”. Am. J. Physiol. Renal Physiol. 285 (4): F784–91. doi:10.1152/ajprenal.00109.2003. PMID 12837682.
  5. ↑ “Entrez Gene: PDZK1IP1 PDZK1 interacting protein 1”.
  6. ↑ Gisler SM, Pribanic S, Bacic D, Forrer P, Gantenbein A, Sabourin LA, Tsuji A, Zhao ZS, Manser E, Biber J, Murer H (Nov 2003). “PDZK1: I. a major scaffolder in brush borders of proximal tubular cells”. Kidney Int. 64 (5): 1733–45. doi:10.1046/j.1523-1755.2003.00266.x. PMID 14531806.
Further reading

Further reading

  • Kocher O, Comella N, Tognazzi K, Brown LF (1998). “Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains”. Lab. Invest. 78 (1): 117–25. PMID 9461128.
  • Göttgens B, Barton LM, Chapman MA, Sinclair AM, Knudsen B, Grafham D, Gilbert JG, Rogers J, Bentley DR, Green AR (2002). “Transcriptional regulation of the stem cell leukemia gene (SCL)–comparative analysis of five vertebrate SCL loci”. Genome Res. 12 (5): 749–59. doi:10.1101/gr.45502. PMC 186570. PMID 11997341.
  • Gisler SM, Pribanic S, Bacic D, Forrer P, Gantenbein A, Sabourin LA, Tsuji A, Zhao ZS, Manser E, Biber J, Murer H (2003). “PDZK1: I. a major scaffolder in brush borders of proximal tubular cells”. Kidney Int. 64 (5): 1733–45. doi:10.1046/j.1523-1755.2003.00266.x. PMID 14531806.
  • Guijarro MV, Castro ME, Romero L, Moneo V, Carnero A (2007). “Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest”. J. Cell. Biochem. 101 (1): 112–21. doi:10.1002/jcb.21163. PMID 17230460.
  • Guijarro MV, Leal JF, Fominaya J, Blanco-Aparicio C, Alonso S, Lleonart M, Castellvi J, Ruiz L, Ramon y Cajal S, Carnero A (2007). “MAP17 overexpression is a common characteristic of carcinomas”. Carcinogenesis. 28 (8): 1646–52. doi:10.1093/carcin/bgm083. PMID 17426052.
  • Guijarro MV, Leal JF, Blanco-Aparicio C, Alonso S, Fominaya J, Lleonart M, Castellvi J, Ramon y Cajal S, Carnero A (2007). “MAP17 enhances the malignant behavior of tumor cells through ROS increase”. Carcinogenesis. 28 (10): 2096–104. doi:10.1093/carcin/bgm124. PMID 17548903.
External links